These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4124610)

  • 1. REM inhibitory effect of L-DOPA infusion during human sleep.
    Gillin JC; Post RM; Wyatt RJ; Goodwin FK; Snyder F; Bunney WE
    Electroencephalogr Clin Neurophysiol; 1973 Aug; 35(2):181-6. PubMed ID: 4124610
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 4. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U
    Psychopharmacologia; 1970 Aug; 18(1):58-67. PubMed ID: 5535577
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 6. L-dopa and REM sleep in normal and mentally retarded subjects.
    Castaldo V; Krynicki VE; Crade M
    Biol Psychiatry; 1973 Jun; 6(3):295-9. PubMed ID: 4354507
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of L-dopa on the sleep of man.
    Wyatt RJ; Chase TN; Scott J; Snyder F; Engleman K
    Nature; 1970 Dec; 228(5275):999-1001. PubMed ID: 4320512
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of the site of the central sympatho-inhibitory action of 1-Dopa in dogs and cats.
    Schmitt H; Fenard S
    Eur J Pharmacol; 1973 May; 22(2):212-6. PubMed ID: 4715222
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of L-dopa.
    Bergonzi P; Chiurulla C; Cianchetti C; Tempesta E
    Confin Neurol; 1974; 36(1):5-22. PubMed ID: 4363375
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sleep privation with eye movements using antidepressive agents].
    Passouant P; Cadilhac J; Ribstein M
    Rev Neurol (Paris); 1972 Jul; 127(1):173-92. PubMed ID: 4358573
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of L-dopa in autism.
    Ritvo ER; Yuwiler A; Geller E; Kales A; Rashkis S; Schicor A; Plotkin S; Axelrod R; Howard C
    J Autism Child Schizophr; 1971; 1(2):190-205. PubMed ID: 4335857
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs.
    Minsker DH; Scriabine A; Stokes AL; Stone CA; Torchiana ML
    Experientia; 1971 May; 27(5):529-31. PubMed ID: 5132586
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sleep in patients with Parkinson's disease and its influence by L-DOPA (author's transl)].
    Schneider E; Maxion H; Ziegler B; Jacobi P
    J Neurol; 1974 Jun; 207(2):95-108. PubMed ID: 4135843
    [No Abstract]   [Full Text] [Related]  

  • 14. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 16. Bizarre social behaviour in rats induced by a combination of a peripheral decarboxylase inhibitor and DOPA.
    Lammers AJ; van Rossum JM
    Eur J Pharmacol; 1968 Dec; 5(1):103-6. PubMed ID: 5718509
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
    Horst WD; Bautz G; Renyi E; Spirt N
    Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of L-DOPA on natural night sleep and on rebound of REM sleep.
    Nakazawa Y; Tachibana H; Kotorii M; Ogata M
    Folia Psychiatr Neurol Jpn; 1973; 27(3):223-30. PubMed ID: 4356561
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of L(-)-dopa on baroreflexes in Parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.